Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease?

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 658-665

  Sullivan, Mark E ^a   Thompson, Cecil S ^a   Dashwood, Michael R ^a   Khan, Masood A ^a   Jeremy, Jamie Y ^b   Morgan, Robert J ^a   Mikhailidis, Dimitri P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cardiovascular risk factors; Diabetes mellitus; Endothelin; Erectile dysfunction; Hypercholesterolaemia; Hypertension; Nitric oxide

Indexed keywords

GUANYLATE CYCLASE; LINSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; PROSTAGLANDIN E1; SILDENAFIL;

AGING; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; ERECTILE DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRACAVERNOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOGENESIS; PENIS DISEASE; PENIS ERECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ENDOTHELIN-1; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PENILE ERECTION; PENIS;

EID: 0033566591     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00135-2     Document Type: Review

References (86)

1. Andersson K.E., Wagner G. Physiology of penile erection. Physiol Rev. 75:1997;191-236.
2. Bush P.A., Aronson W.J., Buga G.M., Rajfer J., Ignarro L.J. Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J Urol. 147:1992;1650-1665.
3. Bush P.A., Aronson W.J., Rajfer J., Buga G.M., Ignarro L.J. Comparison of nonadrenergic, noncholinergic, and nitric oxide-mediated relaxation of corpus cavernosum. Int J Impotence Res. 4:1992;85-93.
4. G-nitroarginine inhibits non-adrenergic, non-cholinergic relaxation of human isolated corpus cavernosum. Acta Physiol Scand. 141:1991;441-442.
5. G-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol Scand. 143:1991;299-304.
6. Holmquist F., Andersson K.E., Hedlund H. Characterisation of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man. J Physiol. 449:1992;295-311.
7. Holmquist F., Fridstrand M., Hedlund H., Andersson K.E. Actions of 3-morpholinosydnonimin (SIN-1) on rabbit isolated penile erectile tissue. J Urol. 150:1993;1310-1315.
8. Ignarro L.J., Bush P.A., Buga G.M., et al. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Comm. 170:1990;843-850.
9. Kim J.H., Azadzoi K.M., Goldstein I., SaenzdeTejada I. A nitric oxide-like factor mediates nonadrenergic, noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest. 88:1991;112-118.
10. Knispel H.H., Goessl C., Beckmann R. Nitric oxide mediates neurogenic relaxation induced in rabbit cavernous smooth muscle by electrical field stimulation. Urology. 40:1992;471-476.
11. Pickard R.S., Powell P.H., Zar M.A. The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve-evoked relaxation of human cavernosal smooth muscle. Br J Pharmacol. 104:1991;755-759.
12. Pickard R.S., Powell P.H., Zar M.A. Nitric oxide and cyclic GMP formation following relaxant nerve stimulation in isolated human corpus cavernosum. Br J Urol. 75:1995;516-522.
13. Rajfer J., Aronson W.J., Bush P.A., Dorey F.J., Ignarro L.J. Nitric oxide as a mediator of relaxation of the corpus cavernosum on response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 326:1992;90-94.
14. Knispel H.H., Goessl C., Beckman R. Basal and acetylcholine-stimulated nitric oxide formation mediates relaxation of rabbit cavernous smooth muscle. J Urol. 146:1991;1429-1433.
15. Knispel H.H., Goessl C., Beckman R. Nitric oxide mediates relaxation in rabbit and human corpus cavernosum smooth muscle. Urol Res. 20:1992;253-257.
16. Burnett A.L., Lowenstein C.J., Bredt D.S., Chang T.S.K., Snyder S.H. Nitric oxide: a physiologic mediator of penile erection. Science. 257:1992;401-403.
17. Alm P., Larsson B., Ekblad E., Sundler F., Andersson K.E. Immunohistochemical localisation of peripheral nitric oxide synthase-containing nerves using antibodies raised against synthetized C- and N-terminal fragments of a cloned enzyme from rat brain. Acta Physiol Scand. 148:1993;421-429.
18. Burnett A.L., Tillman S.L., Chang T.S.K., et al. Immunohistochemical localisation of nitric oxide synthase in the autonomic innervation of the human penis. J Urol. 150:1993;73-76.
19. Keast J.R. A possible neural source of nitric oxide in the rat penis. Neurosci Lett. 143:1992;69-73.
20. Bush P.A., Gonzalez N.E., Ignarro L.J. Biosynthesis of nitric oxide and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum. Biochem Biophys Res Comm. 186:1992;308-314.
21. Forstermann U., Schmidt H.W., Pollock J.S., et al. Isoforms of nitric oxide synthase. Biochem Pharmacol. 42:1991;1849-1857.
22. Kim J.H., Vardi Y., Padma-Nathan H., et al. Oxygen tension regulates erection by modulating nitric oxide production in corpus cavernosum. Int J Impotence Res. 4:(suppl. 2):1992;A3.
23. Kim J.H., Vardi Y., Padma-Nathan H., et al. Oxygen regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest. 91:1993;437-442.
24. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol. 17:(suppl. 3):1991;S25.
25. Martinez-Pineiro L., Trigo-Rocha L.F., Hsu G.L., et al. Cyclic guanosine monophosphate mediates penile erection in the rat. Urol Res. 24:1993;492-499.
26. Boolell M., Allen M.J., Ballard S.A., et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impotence Res. 8:1996;47-52.
27. Stief C.G., Uckert S., Becker A.J., Truss M.C., Jonas U. The effect of specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol. 159:1998;1390-1393.
28. Schmidt P.S., Gupta S., Daley J., SaenzdeTejada I. Mechanisms of nitric oxide-induced relaxation of rabbit corpus cavernosum smooth muscle. J Urol. 153:1995;442A.
29. +-ATPase and human corpus cavernosum smooth muscle contractility. J Urol. 153:1995;442A.
30. Seftel A.D., Viola K.A., Kasner S.E., Ganz M.B. Nitric oxide relaxes rabbit corpus cavernosum smooth muscle via a potassium-conductive pathway. Biochem Biophys Res Comm. 219:1996;382-387.
31. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1993;1273-1286.
32. Burnett A.L., Zeller C.B., Calvin D.C., Crone J.K., Huang P.L. Neuronal nitric oxide synthase (nNOS) gene variants: Genitourinary localisations and functional evidence for compensatory nNOS independent penile erection in nNOS alpha-deficient transgenic mice. J Urol. 159:1998;89. (Abstract 341).
33. Huang P.L., Hyang Z., Mashimo H. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:1995;239-242.
34. Burnett A.L., Calvin D.C., Chamness S.L. Characterisation of neuronal and endothelial nitric oxide synthase (NOS) isoforms in the penis and urethra of wild type mice and transgenic mice lacking neuronal NOS. J Urol. 153:1995;509. (Abstract 1124).
35. Hung A., Vernet D., Xie Y., et al. Expression of the inducible nitric oxide synthase in smooth muscle cells from rat penile corpora cavernosa. J Androl. 16:1995;469.
36. Mills T.M., Wiedmeier V.T., Stopper V.S. Androgen maintenance of erectile function in the rat penis. Biol Reproduc. 46:1992;342-348.
37. Chamness S.L., Ricker D.D., Crone J.K., et al. The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril. 63:1995;1101-1107.
38. Lugg J.A., Rajfer J., Gonzalez-Cadavid N.F. Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. Endocrinology. 136:1995;1495-1501.
39. Lugg J.A., Schlunt K., Rajfer J., Gonzalez-Cadavid N.F. Modulation of nitric oxide synthase activity in the penis by electrical stimulation of the cavernosal nerve. J Urol. 153:1995;509A.
40. McCulloch D.K., Campbell I.W., Fu F.C., Prescott R.J., Clarke B.F. The prevalence of diabetic impotence. Diabetologia. 18:1980;279-283.
41. SaenzdeTejada I., Goldstein I., Azadzoi K.M., Krane R.J., Cohen R.A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 320:1989;1025-1030.
42. Azadzoi K.M., SaenzdeTejada I. Diabetes mellitus impairs neurogenic and endothelium-mediated relaxation of rabbit corpus cavernosum smooth muscle. J Urol. 148:1992;1587-1591.
43. Pickard R.S., King P., Zar M.A., Powell P.H. Corpus cavernosal relaxation in impotent men. Br J Urol. 74:1994;485-491.
44. Sullivan M.E., Bell C.R.W., Dashwood M.R., et al. Autoradiographic localisation of nitric oxide synthase binding sites in normal and diabetic rat corpus cavernosum. Eur Urol. 30:1996;506-511.
45. Hoffman D., Seftel A.D., Hampel N., Resnick M.I. Advanced glycation end-products quench cavernosal nitric oxide. J Urol. 153:1995;441A.
46. Feldman H.A., McKinlay J.B., Goldstein I., Longcope C. Erectile dysfunction, cardiovascular disease and cardiovascular risk factors: prospective results in a large random sample of Massachusetts men. J Urol. 159:1998;91.
47. Wei M. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol. 140:1994;930-937.
48. Sullivan M.E., Dashwood M.R., Thompson C.S., Mikhailidis D.P., Morgan R.J. Decreased endothelin B receptor binding sites on corpus cavernosa of hypercholesterolaemic rabbits. Br J Urol. 1:1998;128-134.
49. Girerd X.J., Hirsch A.T., Cooke J.P., Dzau V.J., Creager M.A. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res. 67:1990;1301-1308.
50. Garban H., Vernet D., Freedman A., Rajfer J., Gonzalez-Cadavid N.F. Effect of aging on nitric oxide-mediated penile erection in rats. Am J Physiol. 268:1995;H467-H475.
51. Carrier S., Hricak H., Lee S., et al. Radiation-induced decrease in nitric oxide synthase-containing nerves in the rat penis. Radiology. 195:1995;95-99.
52. Meyer M.F., Taher A., Krah H., et al. Intracavernous application of SIN-1 in rabbit and man: functional and toxicological results. Ann Urol. 27:1993;179-182.
53. Truss M.C., Becker A.J., Djamilian M.H., Stief C.G., Jonas U. Role of the nitric oxide donor linsidomine chlorohydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction. Urology. 44:1994;553-556.
54. Gingell C.J.C., Jardin A., Olsson A.M., et al. UK-92,480 a new oral therapy for erectile dysfunction, a double blind placebo controlled, once daily dose-response study. J Urol. 155:1996;738.
55. Eardley I., Morgan R.J., Dinsmore W.W., et al. UK-92,480, a new oral therapy for erectile dysfunction, a double blind placebo controlled trial with treatment taken as required. J Urol. 155:1996;737.
56. Sullivan M., Miller M., Bell R., et al. The effects of cigarette smoking on vascular risk factors in patients with erectile dysfunction. Eur Urol. 30:(suppl.2):1996;250.
57. Greenstein A., Chen J., Matzkin H., Villa Y., Braf Z. Does severity of ischaemic coronary disease correlate with erectile function? Int J Impotence Res. 9:1997;123-126.
58. Anderson M., Nicholson B., Louie E., Mulhall J.P. An analysis of vasculogenic erectile dysfunction as a potential predictor of occult cardiac disease. J Urol. 159:1998;30.
59. Bosaller C., Habib G.B., Yamamoto H., et al. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine-5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 79:1987;170-182.
60. Chester A.H., O'Neil G.S., Moncada S., Tadjkarimi S., Yacoub M.H. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 336:1990;897-900.
61. Nabel E.G., Selwyn A.P., Ganz P. Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol. 16:1990;349-356.
62. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidised low-density lipoproteins inhibit relaxations of porcine coronary arteries: Role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 83:1991;2012-2020.
63. Egashira K., Inou T., Hirooka Y., et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 91:1993;29-37.
64. Yaoita H., Sato E., Kawaguchi M., et al. Nonadrenergic Noncholinergic nerves regulate coronary flow via capsaicin-sensitive neuropeptides in the rat heart. Circ Res. 75:1994;780-788.
65. Toda N. Mediation by nitric oxide of neurally-induced human cerebral artery relaxation. Experientia-Basel. 49:1993;51-53.
66. Ayajikl K., Okamura T., Toda N. Nitric oxide mediates and acetylcholine modulates neurally-induced relaxation of bovine cerebral arteries. Neuroscience. 541:1993;819-825.
67. Toda N., Okamura T. Reciprocal regulation by putatively nitroxidergic and adrenergic nerves of monkey and dog temporal arterial tone. Am J Phys. 261:1992;H1740-H1745.
68. Calver A., Collier J., Vallance P. Nitric oxide and cardiovascular control. Exper Physiol. 78:1993;303-326.
69. Khan M.A., Thompson C.S., Sullivan M.E., et al. Endothelin and erectile dysfunction: a target for pharmacological intervention? Expert Opinion Investig Drugs. 7:1998;1759-1767.
70. Jagroop IA, Berwanger C, Stansby G, Mikhailidis DP. Plasma endothelin-1 concentrations in non-insulin dependent diabetes mellitus and non-diabetic patients with chronic arterial obstructive disease of the lower limbs. Intnl Angiol 1999; in press.
71. Lerman A., Edwards B.S., Hallett J.W., et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 325:1991;997-1001.
72. Masaki T., Kimura S., Yanagisawa M., Goto K. Molecular and cellular mechanism of endothelial regulation: implications for vascular function. Circulation. 84:1991;1457-1468.
73. Vanhoutte P.M., Rubanyi G.M., Miller V.M., Houston D.S. Modulation of vascular smooth muscle contraction by the endothelium. Ann Rev Physiol. 48:1986;307-320.
74. Taylor S.G., Weston A.H. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci. 9:1988;272-274.
75. Saenz De Tejada I., Carson M.P., Goldstein I., Traish A.M. Endothelin: localization, synthesis, activity and receptor types in human penile corpus cavernosum. Am J Physiol. 261:1991;H1078-H1085.
76. Christ G.J., Lerner S.E., Kim D.C., Melman A. Endothelin as a putative modulator of erectile physiology and dysfunction. I. Characteristics of ET-1-induced contractions in isolated corporal smooth muscle strips. J Urol. 153:1995;1998-2003.
77. Randall M.D. Vascular activities of endothelins. Pharmacol Ther. 50:1991;73-93.
78. Tabushi Y., Nakamaru M., Rakugi H., et al. Effect of endothelin on neuroeffector junction in mesenteric arteries of hypertensive rat. Hypertension. 15:1990;739-743.
79. Francavilla S., Properzi G., Bellini C., et al. Endothelin-1 in diabetic and nondiabetic men with erectile dysfunction. J Urol. 158:1997;1770-1774.
80. Virag R., Bouilly P., Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet. 1:1985;181-184.
81. Yang Z.H., Richard V., Von Segesser L., et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. Circulation. 82:1990;188-195.
82. Itoh H., Hiraoka N., Higuchi H., et al. Contractile actions of endothelin-1 in isolated helical strips from rat pulmonary artery: potentiation of serotonin-induced contraction. J Cardiovasc Pharmacol. 20:1992;1-6.
83. Henrion D., Laher I. Potentiation of norepinephrine-induced contraction by endothelin-1 in the rabbit aorta. Hypertension. 22:1993;78-83.
84. Batra V.K., McNeill J.R., Xu Y., Wilson T.W., Gopalakrishnan V. ET-B receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am Phys Soc. 264:1993;C479-C484.
85. Durham S.K., Goller N.L., Lynch J.S., Fisher S.M., Rose P.M. Endothelin receptor B expression in the rat and rabbit lung as determined by in situ hybridization using nonisotopic probes. J Cardiovasc Pharmacol. 22:1993;S1-S3.
86. Masaki T., Vane J.R., Vanhoutte P.M.V. International Union of Pharmacology Nomenclature of endothelin receptors. Pharmacol Rev. 46:1994;137-142.